Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
Julie Cardoso, Owner and Executive Director of Independent Diagnostic Testing Facility at Universal Ultrasound Diagnostics, shared a post on LinkedIn:
“Huge milestone for our team at ThinkSono: the FDA has granted clearance for ThinkSono Guidance.
It’s the first AI-powered ultrasound guidance software cleared for the evaluation of suspected deep vein thrombosis (DVT).
What this means in practice: a nurse or clinician with 60–90 minutes of training can capture a vascular ultrasound exam at the bedside, guided in real time by our AI, with every exam reviewed remotely by a qualified interpreting physician.
Faster answers for patients, wherever they present.
It took a decade of work, 1,691 patients across 24 study sites, and an incredible team to get here. Proud to be part of it!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 29, 2026, 17:41Seema Dawood: Difference Between CBC Smear Staining and Cell Counts Staining
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders